Industry News/Joint Venture

Collaboration on Development of Vaccine-Based Products

Published in Hepatitis Weekly, September 11th, 1995

Chiron Corporation, Emeryville, California, and Univax Biologics, Inc., Rockville, Maryland, announced that the two companies have signed an agreement-in-principle to create a long-term collaboration for the development of a new family of human immunotherapeutic products based on the vaccines of Chiron Biocine.

Under this agreement, Univax has exclusive worldwide rights to Chiron Biocine's vaccines for use as immunizing agents for the development of new human immunotherapeutic products. The collaboration capitalizes on the synergies from the concurrently announced proposed merger of Univax and North American Biologicals, Inc. (NABI) in manufacturing and commercializing...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1995-09-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry